| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
| IFN1@ |
|
interferon, type 1, cluster
|
|
|
0.565 |
0.731 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA2 |
P01563
|
interferon alpha 2
|
|
|
0.442 |
0.885 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| IFNB1 |
P01574
|
interferon beta 1
|
|
|
0.421 |
0.846 |
| IGHG3 |
P01860
|
immunoglobulin heavy constant gamma 3 (G3m marker)
|
|
|
0.513 |
0.769 |
| IVL |
P07476
|
involucrin
|
|
|
0.626 |
0.500 |
| KIR2DL2 |
P43627
|
killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 2
|
Receptor
|
|
0.612 |
0.654 |
| KIR2DS1 |
Q14954
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1
|
Receptor
|
|
0.537 |
0.769 |
| KIR3DS1 |
Q14943
|
killer cell immunoglobulin like receptor, three Ig domains and short cytoplasmic tail 1
|
Receptor
|
|
0.617 |
0.692 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| COX3 |
P00414
|
cytochrome c oxidase III
|
Enzyme
|
|
0.546 |
0.808 |
| PDR |
|
pigment disorder, reticulate
|
|
|
0.592 |
0.692 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
| PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
| MBL3P |
|
mannose-binding lectin family member 3, pseudogene
|
|
|
0.518 |
0.769 |
| MEG3 |
|
maternally expressed 3
|
|
|
0.471 |
0.846 |
| GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
| ERVK-6 |
|
endogenous retrovirus group K member 6, envelope
|
|
|
0.521 |
0.808 |
| CBLL2 |
Q8N7E2
|
Cbl proto-oncogene like 2
|
Enzyme
|
|
0.476 |
0.808 |
| COL11A2P1 |
|
collagen type XI alpha 2 pseudogene 1
|
|
|
0.805 |
0.462 |
| MIR125A |
|
microRNA 125a
|
|
|
0.480 |
0.769 |